Lariago-DS Tablet
By Lariago
Rx
5 Tablet in a Strip

Composition
Chloroquine(500mg)

Manufacturer - Ipca Laboratories Ltd
142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra

Expires on or after
September, 2027

liver
When using Lariago-DS Tablet, it is important to exercise caution if you have liver disease. Adjusting the dose of the tablet may be necessary, so it's best to consult your doctor before taking it. Your doctor may recommend regular monitoring of liver function tests while you are on this medication.

kidney
Lariago-DS Tablet requires caution in patients with kidney disease. Consult your doctor for potential dose adjustments.

alcohol
Consult your doctor when consuming alcohol with Lariago-DS Tablet.

driving
Lariago-DS Tablet may cause side effects that can impair driving ability, such as blurred vision and difficulty focusing. Use caution when driving while taking this medication.

pregnancy
Lariago-DS Tablet should be used with caution during pregnancy. Limited human studies suggest potential harm to the developing baby, based on animal studies. Your doctor will assess the risks and benefits before prescribing this medication. It is important to consult your doctor before using Lariago-DS Tablet.

breastfeeding
Lariago-DS Tablet is safe to use while breastfeeding. Studies show it doesn't pass into breast milk in harmful amounts, making it safe for the baby.
Habit Forming | No |
Chemical Class | 4-Aminoquinoline Derivative |
Therapeutic Class | OPHTHAL |
Action Class | Antimalarial- Aminoquinolines |
₹17.1
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024